
About xMD
xMD is a Healthcare company based in Baltimore (United States) founded in 2015. Laboratory instruments and consumables are developed for life science research. xMD has raised $775 thousand across 4 funding rounds from investors including SBIR and TEDCO. xMD offers products and services including Laboratory Instruments and Consumables. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems. Its legal entity is x MD Diagnostics, Inc. Its competitors include 10X Genomics, Cepheid and Fluidigm; 3 of its 3 listed competitors have raised funding.
Company details
xMD was founded in 2015 and is headquartered in Baltimore, United States. Focus is placed on molecular diagnostics tools for research, biopharmaceutical, and clinical laboratory sectors. Proprietary Expression Microdissection technology is employed to isolate, procure, and enrich specific cells from biopsy and specimen samples. Operations center on providing instruments and consumables that support diagnostics in life sciences.
- Headquarters Baltimore, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website xmddiagnostics.com
- Legal Name X Md Diagnostics, Inc.
- Total Equity Funding$775K (USD)
in 4 rounds
- Latest Funding Round$256K (USD), Grant
Aug 2021
- InvestorsSBIR
& 1 more
Products & Services of xMD
xMD offers a comprehensive portfolio of products and services, including Laboratory Instruments and Consumables.
Devices for automating molecular testing in labs
Materials for precision diagnostics and sample enrichment
Funding Insights of xMD
xMD has successfully raised a total of $775K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $256 thousand completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $775,000
- Total Rounds 4
- Last Round Grant β $256,000
- First Round $175,000
(Mar 2017)
- Investors Count 2
All 4 funding rounds of xMD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in xMD
xMD has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include SBIR and TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund and startup accelerator programs focused on seed and early stage companies | 1998 | tedcomd.com | Columbia, United States | |
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States |
Investor details for xMD
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of xMD
4 people are tracked at xMD (4 in leadership).
| Name | Role | Group |
|---|---|---|
Nicole Massoll | Medical Director, Pathologist | Leadership |
Ting Pau Oei | CEO & Co-Chairman | Leadership |
Benjamin Shapiro | Co-Founder & Chief Scientific Officer | Leadership |
Stephen Ritterbush | CFO & Co-Chairman | Leadership |
Complete people profiles for xMD
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of xMD
3 dated milestones of xMD across 6 years, from founding to its latest funding, stage changes and deals.
- Founded xMD is founded.
- Funding First funding round of $175K.
- Funding Latest funding round, Grant, of $256K.
Competitors of xMD
xMD has 3 listed competitors in our database, 3 of them funded. They include 10X Genomics, Cepheid and Fluidigm.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| fluidigm.com | 1999 | San Francisco, United States | $40.53M | 205 | Instruments for life sciences research and applications are developed. |
Detailed competitors of xMD
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of xMD
The website of xMD (xmddiagnostics.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 18.7% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as xMD (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about xMD
xMD was founded in 2015 and raised its 1st funding round 2 years after it was founded.
xMD is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
xMD is a funded company, having raised a total of $775K across 4 funding rounds to date. The company's 1st funding round was a Seed of $175K, raised on Mar 2017.
xMD was founded in 2015 and is headquartered in Baltimore, United States. Focus is placed on molecular diagnostics tools for research, biopharmaceutical, and clinical laboratory sectors. Proprietary Expression Microdissection technology is employed to isolate, procure, and enrich specific cells from biopsy and specimen samples. Operations center on providing instruments and consumables that support diagnostics in life sciences.
xMD's top competitors include Cepheid, 10X Genomics and Fluidigm.
xMD offers Laboratory Instruments and Consumables.
xMD operates through X Md Diagnostics, Inc..